Effect of Metamucil on Bowel Preparation for Colonoscopy

ISRCTN	ISRCTN76623768
DOI	https://doi.org/10.1186/ISRCTN76623768
Protocol serial number	N/A
Sponsor	Procter and Gamble Company (USA)
Funders	Procter and Gamble Company (USA), Wayne State University (USA)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Dr Marc Basson
Scientific

4646 John R
Detroit
48201
United States of America

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Not provided at time of registration
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Bowel Preparation for Colonoscopy
Intervention	Patients randomised to 4 days of Metamucil versus Placebo prior to consuming a standard lavage, followed by colonoscopy
Intervention type	Drug
Phase	Not Specified
Drug / device / biological / vaccine name(s)	Metamucil
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	01/01/2003

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Target sample size at registration	64
Key inclusion criteria	Patients scheduled for colonoscopy using a standard lavage preparation
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/01/2002
Date of final enrolment	01/01/2003

4646 John R

Detroit
48201
United States of America

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	Results	02/02/2004		Yes	No